Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Autoimmune Lymphoproliferative Syndrome

fluorodeoxyglucose f18 has been researched along with Autoimmune Lymphoproliferative Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avila, NA; Carrasquillo, JA; Chen, CC; Jaffe, ES; Pittaluga, S; Price, S; Rao, VK; Whatley, M1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Autoimmune Lymphoproliferative Syndrome

ArticleYear
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Autoimmune Lymphoproliferative Syndrome; Child; Child, Preschool; fas Receptor; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mutation; Positron-Emission Tomography; Splenomegaly; Tissue Distribution; Young Adult

2019